Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). by Gachon, F. et al.
Virology 299, 271–278 (2002)Activation of HTLV-I Transcription in the Presence of Tax Is Independent
of the Acetylation of CREB-2 (ATF-4)
F. Gachon,1 C. Devaux, and J.-M. Mesnard2
Laboratoire Infections Re´trovirales et Signalisation Cellulaire, CNRS EP 2104/Universite´ Montpellier I, Institut de Biologie,
4 Bd Henri IV, 34060 Montpellier, France
Received December 14, 2001; returned to author for revision February 22, 2002; accepted March 22, 2002
We have previously demonstrated that the bZIP transcription factor CREB-2, also called ATF-4, trans-activates, in
association with the viral protein Tax, the human T-cell leukemia virus type I (HTLV-I) promoter. In this study, we have
examined whether CREB-2 acetylation affects transcriptional activation mediated by Tax. We present evidence that CREB-2
is acetylated in vitro and in vivo. CREB-2 is acetylated in two regions: the basic domain of the bZIP (from amino acid residue
270 to 300) and the short basic domain (from 342 to 351) located downstream from the bZIP. We also demonstrate that
CREB-2 is acetylated by p300/CBP but not by p/CAF. Moreover, replacement of lysine by arginine in the basic domains
decreases the trans-activating capacity of CREB-2. However, in the presence of Tax, the HTLV-I transcription remains fully
activated by these CREB-2 mutants. Although we cannot totally exclude that the mutations could also affect CREB-2 structureINTRODUCTION
Human T-cell leukemia virus type I (HTLV-I) is the
etiologic agent of adult T-cell leukemia (ATL). The viral
Tax protein has been proposed to contribute to the pro-
liferation and the transformation of T-cells by HTLV-I
(reviewed in Mesnard and Devaux, 1999; Yoshida, 2001).
Tax is also a potent transactivator of transcription from
the viral long terminal repeat (LTR) promoter (Cann et al.,
1985; Felber et al., 1985; Fujisawa et al., 1985; Sodroski et
al., 1985). The HTLV-I LTR contains important elements
needed for Tax trans-activation corresponding to three
repeats of 21-bp sequence called Tax-responsive ele-
ments (TxREs) (Fujisawa et al., 1986; Shimotohno et al.,
1986). The viral TxREs are composed of a central cyclic-
AMP response element (CRE)-like motif, flanked by short
runs of guanine and cytosine base pairs. However, Tax is
unable to interact specifically with the CRE site and, in
fact, is associated with the viral LTR through interactions
with CRE-binding proteins. Different members of the ac-
tivating transcription factor/CRE-binding protein (ATF/
CREB) family such as CREB (Zhao and Giam, 1992;
Franklin et al., 1993; Yin and Gaynor, 1996), CREM (Su-
zuki et al., 1993), and CREB-2 (Reddy et al., 1997; Gachon
et al., 1998) were shown to be able to stimulate viral
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Switzerland.271transcription in the presence of Tax. The ATF/CREB pro-
teins are characterized by basic-leucine zipper (bZIP)
C-terminal structures required for DNA binding and pro-
tein dimerization. Tax enhances the binding of CREB
(Zhao and Giam, 1992; Franklin et al., 1993; Yin and
Gaynor, 1996), CREM (Suzuki et al., 1993), and CREB-2
(Gachon et al., 2000) to the TxREs, probably by stabilizing
the LTR-bound complexes through direct contacts with
nucleotides flanking the CRE-like motifs (Kimzey and
Dynan, 1998; Lenzmeier et al., 1998; Lundblad et al.,
1998). It has also been suggested that Tax could in-
crease the DNA-binding activity of ATF/CREB factors by
promoting dimerization of their bZIP domain (Wagner and
Green, 1993). Then, the TxRE-associated Tax molecule is
able to recruit histone acetyltransferases (HATs), such as
the CREB-binding protein (CBP) and its homolog, p300
(Kwok et al., 1996), or the p300/CBP-associated factor
(p/CAF) (Jiang et al., 1999) and basal polymerase II fac-
tors such as the transcription factors TFIIA (Clemens et
al., 1996) or TFIID through TATA-binding protein (TBP)
(Caron et al., 1993) and TBP-associated factor TAFII28
(Caron et al., 1997).
CREB-2 (Karpinski et al., 1992), also called ATF-4 or
TAXREB-67 (Hai et al., 1989; Tsujimoto et al., 1991), to-
gether with the mouse mATF-4, mTR67, C/ATF, and the
Aplysia ApCREB-2, represent a subfamily of the ATF/
CREB proteins (Hai and Hartman, 2001). CREB-2 con-
tains a constitutive activation domain of transcription that
can directly interact with p300/CBP (Liang and Hai, 1997;and activity independent of acetylation, our results sugge
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CCAAT/enhancer-binding protein (C/EBP) families rather
than proteins of the ATF/CREB family (Hai and Curran,
1991; Vinson et al., 1993; Gachon et al., 2001). Het-
erodimerization of CREB-2 represents a powerful means
to regulate its transcriptional activity and consequently
the expression of its target genes. Thus, we recently
demonstrated that the heterodimerization of CREB-2 with
C/EBP-homologous protein (CHOP) downregulated the
HTLV-I transcription (Gachon et al., 2001). Acetylation is
also a key mechanism used by the cell to control the
activity of a transcription factor. For instance, acetylation
of p53 and GATA-1 by p300/CBP (Gu and Roeder, 1997;
Boyes et al., 1998) increases their transcriptional activity,
while acetylation of T-cell factor (TCF) represses its ac-
tivity (Waltzer and Bienz, 1998). Because CREB-2 inter-
acts with p300/CBP (Liang and Hai, 1997; Gachon et al.,
2000), we explored the possibility that CREB-2 is also
regulated by acetylation and we studied the effects of the
CREB-2 acetylation on the HTLV-I transcription. Our re-
sults demonstrate that CREB-2 is acetylated by p300/
CBP but suggest, however, that in the presence of Tax
the activation of HTLV-I transcription is independent of
the CREB-2 acetylation.
RESULTS
CREB-2 is acetylated in vitro and in vivo
Acetylation has been shown to regulate the activity of
many transcription factors. The C-terminal region of
CREB-2 including the bZIP domain (Fig. 1) contains ly-
sine residues that are flanked by sequences conform to
the consensus for the acetylation of nonhistone proteins
(K/RXKK) suggested from studies of p53 and GATA-1
acetylation (Gu and Roeder, 1997; Boyes et al., 1998). To
determine whether CREB-2 is acetylated, a GST-CREB-2
fusion protein bound to glutathione-Sepharose beads
was incubated with CEM nuclear extract, extensively
washed, and subjected to an acetyltransferase assay. As
shown in Fig. 2A, GST-CREB-2 was acetylated but not
GST alone, showing that the in vitro acetylation was
specific to CREB-2. In addition, the same assay was
performed with Tax but we detected no acetylation, sug-
FIG. 1. Schematic diagram of transcription factor CREB-2. The C-terminal part of CREB-2 contains, in addition to the bZIP domain, a short basic
region corresponding to the last 10 amino acid residues (from 342 to 351). We have already demonstrated that the leucine zipper and the short basic
C-terminal domain of CREB-2 are required for interacting with Tax (Gachon et al., 2000). Both basic domains and the leucine zipper are indicated by
the grayish and stripped boxes, respectively. The amino acid sequence of the C-terminal part (from 270 to 351) is indicated.
FIG. 2. CREB-2 is acetylated in vitro and in vivo. (A) In vitro acetylation of CREB-2. Equivalent amount of GST and GST-CREB-2 bound to
glutathione-Sepharose beads were incubated with CEM nuclear extract, extensively washed, and subjected to an acetyltransferase assay. Reaction
products were separated by 10% SDS–PAGE and the gel was Coomassie blue stained, dried, and visualized by autoradiography. (B) CREB-2 is
acetylated in vivo. Extract from CEM cells pulsed with 3H-sodium acetate was subjected to immunoprecipitation with preimmune serum or CREB-2
antiserum and immunoprecipitated proteins were analyzed by 10% SDS–PAGE followed by autoradiography.
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gesting that Tax is probably not acetylated (data not
shown).
To verify CREB-2 acetylation in vivo, CEM cells were
biosynthetically labeled for 1.5 h with 3H-sodium acetate.
The cells were lysed and protein was immunoprecipi-
tated using an anti-CREB-2 serum. Figure 2B shows that
cellular CREB-2 was acetylated. No signal was detected
in the control immunoprecipitate from the same extract
using preimmune serum. These results show that acet-
ylation of CREB-2 occurs in vivo.
Acetylation of the basic C-terminal domains
of CREB-2 by p300/CBP
The sites of acetylation within the 351 amino acids of
CREB-2 were mapped using a panel of CREB-2 GST-
fusion fragments spanning the full-length protein. The
GST-fusion fragments prebound to glutathione-Sepha-
rose were incubated with CEM nuclear extract and ra-
dioactive acetyl-CoA as described above. Acetylation
was detected in the C-terminal region of CREB-2 (Fig. 3),
including not only the basic domain of the bZIP (from
amino acid residue 270 to 300) but also the short basic
domain (from 342 to 351) located downstream from the
bZIP (Fig. 1). However, the GST-fusion protein containing
only the CREB-2 C-terminal domain (from 263 to 351) was
not acetylated after incubation with nuclear extract, sug-
gesting that the cellular acetyltransferase that is involved
in the CREB-2 acetylation is unable to interact with the
C-terminal region of CREB-2.
Among the nuclear HATs identified and characterized
FIG. 3. Identification of acetylated domains of CREB-2. (A) Schematic representation of the CREB-2 fragments used for the acetyltransferase assay.
(B) Acetylation of CREB-2 occurs at sites located in its C-terminal basic domains. GST-CREB-2 fragments on glutathione-Sepharose beads were
incubated with CEM nuclear extract and 3H-acetyl-CoA. Acetylated proteins were resolved by 10% SDS–PAGE.
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to date, p300/CBP has been shown to interact with
CREB-2 (Liang and Hai, 1997; Gachon et al., 2000). In
addition, our previous studies using truncated proteins
have shown that p300/CBP is unable to interact in vivo
with the C-terminal region of CREB-2 (Gachon et al.,
2000). Taken together, these results suggest that p300/
CBP could be involved in CREB-2 acetylation. To test this
possibility, we performed in vitro acetylation assays us-
ing purified CREB-2 and GST-p300 HAT domain. Figure 4
shows that CREB-2 was acetylated by p300. On the other
hand, when the same experiment was carried out with
the HAT domain of p/CAF, CREB-2 was not acetylated
(Fig. 4). These results strongly suggest that CREB-2 is
acetylated by p300 but not by p/CAF.
Activation of HTLV-I transcription in the presence of
Tax is independent of the acetylation of CREB-2
We wanted to determine whether acetylation of
CREB-2 influences the HTLV-I transcription in the pres-
ence of Tax. We argued that identification of the lysines
modified by p300 may give clues to the CREB-2 regula-
tion by acetylation. Deletion analysis indicated that acet-
ylation sites resided within the C-terminal region of
CREB-2 (see Fig. 3) that contains several lysines. For this
reason, we first mutated the lysine residues (to arginine)
that were flanked by sequences well conformed to the
consensus for the acetylation of nonhistone proteins (Gu
and Roeder, 1997; Boyes et al., 1998). Three mutated
lysines are within the short basic domain downstream
from the bZIP (mutant M4) and the other mutated lysines
(mutants M1, M2, M3, and M5) are in the basic domain of
the bZIP (Fig. 5), some of which are implicated in the
nuclear targeting of CREB-2 (KKLKK) (Cibelli et al.,1999)
and probably in DNA binding.
The transcriptional activity of the mutants were tested
by transient-transfection assays performed in CEM cells
cotransfected with a luciferase reporter construct with a
promoter containing three tandemly repeated copies of
the cellular CRE site. Figure 5 shows that the transcrip-
tional activity of the CREB-2 mutants M4 and M5 have
significantly decreased, suggesting that acetylation of
both basic domains are involved in the regulation of
CREB-2 activity. Moreover, when the short basic C-termi-
nal domain was completely deleted (mutant M), the
transcriptional activity of CREB-2 decreased drastically
(Fig. 5). Western blot analysis showed that the reduction
of activity was not due to the lack of expression of the
mutant CREB-2 proteins (data not shown). To determine
whether the mutated lysines of M4 and M5 were effec-
tively involved in acetylation of CREB-2, we performed in
vitro acetylation assays using GST-p300 HAT domain.
However, we were unable by this approach to discern
significant changes in acetylation levels among the mu-
tants (data not shown). For this reason, we mutated the
other lysine residues present in the basic domain of the
bZIP (mutants M6, M7, and M8). Although we detected a
reduction of transcriptional activity for M8 (Fig. 5), again
no significant reduction of acetylation was observed with
this mutant (data not shown). This absence of difference
in acetylation levels between the mutants confirm that
multiple sites are acetylated, both in the basic domains
(amino acid residues 270–300 and 342–351).
When the cotransfections were performed with Tax
and a promoter containing three tandem copies of the
HTLV-I promoter-proximal TxRE, M4, M5, and M8 were
able to function as full activators of the HTLV-I transcrip-
tion (Fig. 5). On the other hand, M remained unable to
stimulate the viral transcription. This absence of tran-
scription stimulation by the mutant M is obviously due
to the incapacity of the mutant to interact with Tax.
FIG. 4. CREB-2 is acetylated by p300 but not by p/CAF. Purified CREB-2 was incubated with 3H-acetyl-CoA and recombinant GST-p/CAF HAT or
GST-p300 HAT. Reaction products were separated by SDS–PAGE and gels were autoradiographed. The products of autoacetylation, GST-p/CAF HAT,
and GST-p300, used as positive controls, are indicated by arrows. The reactions were carried out with GST as negative controls.
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Indeed, we have previously demonstrated that the short
basic C-terminal domain of CREB-2 is required for inter-
action with Tax and when this domain is completely
deleted CREB-2 is no longer able to interact with Tax
(Gachon et al., 2000). Taken together, our results show
that the mutations of the lysine residues to arginine in
the basic domains of CREB-2 affect its transcriptional
activity. However, we find that the mutants remain capa-
ble of activating the viral transcription in the presence of
Tax.
DISCUSSION
Several transcription factors that recruit p300/CBP and
other coactivators possessing HAT activity have been
shown to be acetylated. We and others have shown that
CREB-2 interacts with p300/CBP (Liang and Hai, 1997;
Gachon et al., 2000). Here, we demonstrate that CREB-2
is acetylated in vivo and p300 acetylates CREB-2 in vitro.
We also show that CREB-2 is acetylated in two regions:
the basic domain of the bZIP (from amino acid residue
270 to 300) and the short basic domain (from 342 to 351)
located downstream from the bZIP. When the lysine res-
idues present in these basic domains are mutated into
arginine, the CREB-2 transcriptional activity decreases
significantly. However, when we performed in vitro acet-
ylation assays, we were unable to discern significant
changes in acetylation levels of the mutants. Although
this result is probably due to the existence of multiple
acetylation sites present in the C-terminal region of
CREB-2, we cannot totally exclude that the mutations
could also affect CREB-2 structure and activity indepen-
dent of acetylation.
On the other hand, in the presence of Tax, the HTLV-I
transcription remains fully activated by these CREB-2
mutants, Tax counteracting the negative effect of the
mutations. For the moment, we do not know why Tax is
able to have such an effect. We have demonstrated that
Tax interacted with CREB-2 bound to the three TxREs of
the LTR promoter and stabilized the complex CREB-2/
TxRE (Gachon et al., 2000). Then, the LTR-associated Tax
molecule is able to recruit p300/CBP (Kwok et al., 1996).
Acetylation may also modulate a number of functional
properties of a transcription factor such as CREB-2, in-
cluding its sequence-specific DNA-binding activity, pro-
tein–protein interactions, and nucleocytoplasmic shut-
tling. Among the CREB-2 mutants that we have produced,
some contain mutations in the region of CREB-2 involved
in its nuclear targeting (Cibelli et al.,1999). However, it is
obvious that acetylation of CREB-2 is not involved in its
transport to the nucleus since all these mutants are still
able to stimulate, in the presence of Tax, the viral tran-
scription that occurs in the nucleus (Bex et al., 1998).
Acetylation of CREB-2 could enhance its association with
p300/CBP, as it has been recently described for c-Myb
(Sano and Ishii, 2001). However, if this was the case, this
effect would be indirect because we have found that the
bZIP region of CREB-2 does not interact with p300/CBP
in vivo (Gachon et al., 2000). At least, acetylation of
CREB-2 could enhance the DNA affinity of CREB-2 for the
CRE motif. This possibility could explain why the CREB-2
FIG. 5. Phenotypic analysis of the CREB-2 mutants. Functional properties of the CREB-2 mutants were analyzed by cotransfecting CEM cells with
2 g of luciferase gene driven by three tandem copies of the cellular palindromic CRE site or by three tandem copies of the viral promoter-proximal
TxRE (in the presence of 1 g of pSG-Tax), 5 g of pAC1 (-galactosidase containing reference plasmid), and 10 g of CREB-2 expression vector.
The total amount of DNA in each series of transfection was equal, the balance being made up with the empty plasmids. The luciferase values were
normalized for -galactosidase activity and are presented as a percentage of the activity observed in cells transfected with the wild-type CREB-2. The
values represent the mean  SD (n  3).
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mutants would be able to stimulate the viral transcription
in the presence of Tax since Tax stabilizes the associa-
tion between CREB-2 and TxRE by contacting nucleo-
tides flanking the viral CRE-like motif (Kimzey and Dynan,
1998; Lenzmeier et al., 1998; Lundblad et al., 1998). This
possibility should be investigated further to demonstrate
the exact effect of acetylation on the transcriptional ac-
tivity of CREB-2.
It is not the first time that Tax is described to be able
to trans-activate the viral transcription independently of
the modifications that are involved in the regulation of
the activity of the transcription factors. Thus, CREB par-
ticipates in Tax-mediated activation of the HTLV-I pro-
moter without being phosphorylated by the protein ki-
nase A (Laurance et al., 1997), whereas CREB normally
interacts with p300/CBP in a phosphorylation-dependent
manner (Chrivia et al., 1993; Kwok et al., 1994). All these
observations confirm that the main function of the bZIP
factors such as CREB and CREB-2, that bind to the viral
promoter, is to provide a bridge between the viral pro-
moter and Tax, Tax recruiting in turn p300/CBP to acti-
vate the viral transcription. Actually, we do not know
whether p300/CBP is able to acetylate CREB-2 when
CREB-2 is associated with Tax on the viral promoter. On
the other hand, we did not detect any acetylation of Tax,
suggesting that Tax is probably not acetylated by p300/
CBP. Taken together, these observations suggest that the
main function of the p300/CBP recruitment to the HTLV-I
promoter could be to induce local nucleosome modifica-
tions by histone acetylation and facilitate stable binding
of components of the basal transcription machinery.
MATERIALS AND METHODS
Plasmids, mutagenesis, and transfections
The expression vectors pSG-Tax and pCI-CREB-2, and
the luciferase reporter plasmid pminLUC-viral TxRE and
pminLUC-cellular CRE, have been previously described
(Gachon et al., 2000). Point mutations in the CREB-2
cDNA were performed by using the Altered Sites II Mam-
malian Mutagenesis System kit (Promega) according to
the manufacturer’s instructions and verified by DNA se-
quencing. The full-length CREB-2 and the mutated
CREB-2 cDNAs were subcloned into the pGex bacterial
expression vector and the glutathione S-transferase
(GST)-tagged proteins were purified as described (Ga-
chon et al., 1998). The pGex plasmids allowing the ex-
pression of the HAT domains of p300 and p/CAF were
generous gifts from Eric Verdin and Tony Kouzarides,
respectively.
The lymphoblastoid CEM cell line was obtained from
the American Type Culture Collection (Bethesda, MD).
Cells were cultured in RPMI 1640 medium supplemented
with 1% penicillin streptomycin antibiotic mixture, 1%
glutamax (Life Technologies, Eragny, France), and 10%
FCS (Life Technologies) to a density of 5  105 cells/ml
in a 5% CO2 atmosphere. CEM cells were transiently
cotransfected according to the previously published pro-
cedure (The´bault et al., 2000). Five micrograms of a
-galactosidase-containing plasmid (pAC1) was in-
cluded in each transfection for controlling of the trans-
fection efficiency. The total amount of DNA in each series
of transfection was equal, the balance being made up
with empty pSG-5 or pCI-neo vector. Cell extracts equal-
ized for protein content were used for luciferase and
-galactosidase assays (The´bault et al., 2000).
GST pull-downs from nuclear extract
GST-fusion proteins prebound to glutathione-Sepha-
rose beads were incubated with 100 g CEM nuclear
extract protein prepared as already described (Lemas-
son et al., 1998) in 500 l of 20 mM HEPES pH 7.6, 100
mM KCl, 1 mM DTT, 0.1 mM EDTA, 10% glycerol, and 0.1%
NP-40 for 2 h. Beads were washed five times in 500 l of
the same buffer with 250 mM KCl and resuspended in 20
l of acetylation buffer.
Acetyltransferase assays
After incubation with nuclear extract, GST-fusion pro-
teins were incubated at 30°C for 1 h with 0.25 Ci of
3H-acetyl-CoA (ICN) in acetylation buffer containing 50
mM HEPES pH 8.0, 1 mM DTT, 10% glycerol, 0.2 mM
phenylmethylsulfonyl fluoride, and 10 mM sodium bu-
tyrate. Proteins were resolved by SDS–PAGE; the gels
were fixed by Coomassie blue staining and subjected to
signal amplification (Amplify; Amersham) prior to expos-
ing to X-ray film. For the tests with p300 and p/CAF,
CREB-2, subcloned into the pQE bacterial expression
vector and purified as already described (Gachon et al.,
2000), was incubated for 0.5 h in the presence of the HAT
domain of p300 (amino acid residues 1195–1810) or
p/CAF(amino acid residues 352–658) in the same condi-
tions than that presented above.
in vivo [3H]sodium acetate labeling and
immunoprecipitations
Forty million exponentially CEM cells were centrifuged
and resuspended in 5 ml of medium containing 1 mCi of
[3H]sodium acetate per ml (10 Ci/mmol; ICN) and 50 nM
Trichostatin (Sigma) and incubated for 1.5 h. The cells
were lysed in 50 mM Tris pH 8.0, 150 mM NaCl, 1 mM
DTT, 1 mM EDTA, 1% Triton X-100, 0.2 mM phenylmeth-
ylsulfonyl fluoride, and 10 mM sodium butyrate. Cell
lysates were centrifuged at 10,000 g for 5 min and equal
amounts of proteins (1 mg) were immunoprecipitated
with polyclonal CREB-2 antibodies (Santa Cruz Biotech-
nology Inc., Santa Cruz, CA) or preimmune serum. The
antibodies were captured by adding 15 l of a 50% slurry
of protein A-Sepharose. After washing five times in the
same buffer, immunoprecipitates were resolved by SDS–
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PAGE, fixed, and subjected to signal amplification and
autoradiographed.
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